Shih-i Chen

TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Epigenetic corepressor BCORL1 predominates as a driver of clonal hematopoiesis of indeterminate potential in patients undergoing chronic hemodialysis: a multicenter cohort study.

Epigenetic corepressor BCORL1 predominates as a driver of clonal hematopoiesis of indeterminate potential in patients undergoing chronic hemodialysis: a multicenter cohort study.

Journal: Human genomics

Published: January 22, 2026

Predictive factors and survival associated with varying degrees of cytopenia in patients undergoing chronic Hemodialysis: A cohort study.

Predictive factors and survival associated with varying degrees of cytopenia in patients undergoing chronic Hemodialysis: A cohort study.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: August 13, 2025

Humeral and cellular immune responses to SARS-CoV-2 vaccination in patients on peritoneal dialysis.

Humeral and cellular immune responses to SARS-CoV-2 vaccination in patients on peritoneal dialysis.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: November 09, 2022

Gustatory Function and the Uremic Toxin, Phosphate, Are Modulators of the Risk of Vascular Calcification among Patients with Chronic Kidney Disease: A Pilot Study.

Gustatory Function and the Uremic Toxin, Phosphate, Are Modulators of the Risk of Vascular Calcification among Patients with Chronic Kidney Disease: A Pilot Study.

Journal: Toxins

Published: May 18, 2020

Gustatory Dysfunction Is Closely Associated With Frailty in Patients With Chronic Kidney Disease.

Gustatory Dysfunction Is Closely Associated With Frailty in Patients With Chronic Kidney Disease.

Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation

Published: March 27, 2020

Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial.

Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial.

Journal: Gut

Published: April 22, 2014

Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.

Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.

Journal: Annals of internal medicine

Published: December 04, 2013

Increased procollagen type I C-terminal peptide levels indicate diastolic dysfunction in end-stage renal disease patients undergoing maintenance dialysis therapy.

Increased procollagen type I C-terminal peptide levels indicate diastolic dysfunction in end-stage renal disease patients undergoing maintenance dialysis therapy.

Journal: Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography

Published: November 28, 2011

Showing 1-8 of 8

Last Updated: 09/26/2026